Reference Intervals
CSF marker
|
Normal Reference (ng/L)
|
Abeta1-42
|
> 1030
|
Phospho-tau (P-tau)181
|
≤ 27
|
Total-tau (T-tau)
|
≤ 300
|
P-tau/Abeta1-42
|
≤ 0.023
|
T-tau/Abeta1-42
|
≤ 0.28
|
The CSF biomarkers Abeta1-42 and P-tau levels and the P-tau/Abeta1-42 ratio offer approximately 85-95% predictive value for
supporting underlying Alzheimer's disease neuropathologic changes based on Abeta amyloid-PET imaging (1).
The normal reference ranges are based on strictly defined pre-analytical handling parameters for CSF specimens. Failure to adhere to
the collection instructions may result in falsely low Abeta1-42 concentrations, affecting the interpretation (2).
*Note: As of 28/02/2022, the Roche Elecsys Immunoassay Generation II for CSF is used for testing.
The phone number to discuss this report is 03 9035 7243 (NDDL)
1. Hansson et al.,Alzheimer's & Dementia 2018; 14: 1470; Schindler et al. Alzheimer’s & Dementia 14 (2018) 1460.
2. https://pim-eservices.roche.com/eLD/api/downloads/7aa19107-2bbd-eb11-0391-005056a772fd?countryIsoCode=au
|